SOURCE: Hansen Medical, Inc.

Hansen Medical, Inc.

October 21, 2010 18:10 ET

Hansen Medical Announces 2010 Third Quarter Results Conference Call

MOUNTAIN VIEW, CA--(Marketwire - October 21, 2010) -  Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced today that it will release its financial and operating results for the third quarter ended September 30, 2010 after market close on Wednesday, November 3, 2010.

Hansen Medical will host a conference call at 5:00 p.m. ET (2:00 p.m. PT) on November 3, 2010 to discuss its results. The call may be accessed by dialing 877-941-2321 (480-629-9714 for international callers) and via the Internet in the Investor Relations section of Hansen Medical's website at Please go to the website at least 15 minutes early to register, download and install any necessary audio software. Following the call, a webcast replay will be available on Hansen Medical's website, and an audio replay will also be available by calling 877-870-5176 (858-384-5517 for international callers) and entering the access code 4379093. The audio replay will be available through November 10, 2010.

About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. The company's Sensei® system and its Sensei X Robotic Catheter System were cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in electrophysiology (EP) procedures. The flexible robotic platform is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. The safety and effectiveness of the Sensei and Sensei X systems for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established. In the European Union, the Sensei and the Sensei X systems are cleared for use during EP procedures, such as guiding catheters in the treatment of AF. Additional information can be found at

Contact Information

  • Investor Contacts:
    Peter Osborne
    Interim CFO
    Hansen Medical

    Matt Clawson
    Allen & Caron Inc
    Email Contact